Short- and Long-Term Effects of Different Antibiotics on the Gut Microbiota and Cytokines Level in Mice

References

• Rodrigues RR, Greer RL, Dong X, et al. Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice. Front Microbiol. 2017;8:2306. doi:10.3389/fmicb.2017.02306
   Web of Science ®Google Scholar
• Bailey LC, Forrest CB, Zhang P, et al. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014;168(11):1063–1069. doi:10.1001/jamapediatrics.2014.1539
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Gerner RR, et al. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33(6):954–964. doi:10.1016/j.ccell.2018.03.004
   PubMed Web of Science ®Google Scholar
• Routy B, Gopalakrishnan V, Daillere R, et al. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018;15(6):382–396. doi:10.1038/s41571-018-0006-2
   PubMed Web of Science ®Google Scholar
• Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226–236. doi:10.1136/gutjnl-2017-314205
   PubMed Web of Science ®Google Scholar
• Ogino S, Nowak JA, Hamada T, et al. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018;67(6):1168–1180. doi:10.1136/gutjnl-2017-315537
   PubMed Web of Science ®Google Scholar
• Lavelle A, Hoffmann TW, Pham H-P, et al. Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host. Microbiome. 2019;7(1):111. doi:10.1186/s40168-019-0725-3
   PubMed Web of Science ®Google Scholar
• Ferrer M, Mendez-Garcia C, Rojo D, et al. Antibiotic use and microbiome function. Biochem Pharmacol. 2017;134:114–126. doi:10.1016/j.bcp.2016.09.007
   PubMed Web of Science ®Google Scholar
• Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018;3(11):1255–1265. doi:10.1038/s41564-018-0257-9
   PubMed Web of Science ®Google Scholar
• Guo Y, Yang X, Qi Y, et al. Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system. Sci Rep. 2017;7(1):43035. doi:10.1038/srep43035
   PubMed Web of Science ®Google Scholar
• Sun L, Zhang X, Zhang Y, et al. Antibiotic-induced disruption of gut microbiota alters local metabolomes and immune responses. Front Cell Infect Microbiol. 2019;9:99. doi:10.3389/fcimb.2019.00099
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu J, Chen Z, et al. Integrated analysis of the alterations in gut microbiota and metabolites of mice induced after long-term intervention with different antibiotics. Front Microbiol. 2022;13:832915. doi:10.3389/fmicb.2022.832915
   Web of Science ®Google Scholar
• Angoa-Perez M, Zagorac B, Francescutti DM, et al. Effects of gut microbiota remodeling on the dysbiosis induced by high fat diet in a mouse model of Gulf war illness. Life Sci. 2021;279:119675. doi:10.1016/j.lfs.2021.119675
   Web of Science ®Google Scholar
• Greenwood C, Morrow AL, Lagomarcino AJ, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr. 2014;165(1):23–29. doi:10.1016/j.jpeds.2014.01.010
   PubMed Web of Science ®Google Scholar
• Bhalodi AA, van Engelen TSR, Virk HS, et al. Impact of antimicrobial therapy on the gut microbiome. J Antimicrob Chemother. 2019;74(Suppl 1):i6–i15. doi:10.1093/jac/dky530
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Beldavs ZG, et al. Prevalence of antimicrobial use in US acute care hospitals, May–September 2011. JAMA. 2014;312(14):1438–1446. doi:10.1001/jama.2014.12923
   PubMed Web of Science ®Google Scholar
• Ng KM, Aranda-Diaz A, Tropini C, et al. Recovery of the gut microbiota after antibiotics depends on host diet, community context, and environmental reservoirs. Cell Host Microbe. 2020;28(4):628. doi:10.1016/j.chom.2020.09.001
   Web of Science ®Google Scholar
• Gamage H, Venturini C, Tetu SG, et al. Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients. Sci Rep. 2021;11(1):7252. doi:10.1038/s41598-021-85946-4
   Web of Science ®Google Scholar
• Jump RLP, Kraft D, Hurless K, et al. Impact of tigecycline versus other antibiotics on the fecal metabolome and on colonization resistance to clostridium difficile in mice. Pathog Immun. 2017;2(1):1–20. doi:10.20411/pai.v2i1.159
   PubMedGoogle Scholar
• Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003;63(24):2769–2802. doi:10.2165/00003495-200363240-00008
   PubMed Web of Science ®Google Scholar
• Rice LB, Hutton-Thomas R, Lakticova V, et al. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis. 2004;189(6):1113–1118. doi:10.1086/382086
   Web of Science ®Google Scholar
• Gu S, Chen Y, Zhang X, et al. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect. 2016;18(1):30–38. doi:10.1016/j.micinf.2015.09.008
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4516–4522. doi:10.1073/pnas.1000080107
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi:10.1093/bioinformatics/btu170
   PubMed Web of Science ®Google Scholar
• Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957–2963. doi:10.1093/bioinformatics/btr507
   PubMed Web of Science ®Google Scholar
• Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27(16):2194–2200. doi:10.1093/bioinformatics/btr381
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.2604
   PubMed Web of Science ®Google Scholar
• McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217
   PubMed Web of Science ®Google Scholar
• Nicolaou KC, Rigol S. A brief history of antibiotics and select advances in their synthesis. J Antibiot. 2018;71(2):153–184.
   PubMed Web of Science ®Google Scholar
• Benko R, Gajdacs M, Matuz M, et al. Prevalence and antibiotic resistance of ESKAPE pathogens isolated in the emergency department of a tertiary care teaching hospital in Hungary: a 5-year retrospective survey. Antibiotics. 2020;9(9):624. doi:10.3390/antibiotics9090624
   Web of Science ®Google Scholar
• Jones-Nelson O, Tovchigrechko A, Glover MS, et al. Antibacterial monoclonal antibodies do not disrupt the intestinal microbiome or its function. Antimicrob Agents Chemother. 2020;64(5). doi:10.1128/AAC.02347-19
   Web of Science ®Google Scholar
• De Schepper S, Verheijden S, Aguilera-Lizarraga J, et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell. 2019;176(3):676. doi:10.1016/j.cell.2019.01.010
   Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9
   PubMed Web of Science ®Google Scholar
• Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279(1):90–105. doi:10.1111/imr.12563
   PubMed Web of Science ®Google Scholar
• Litvak Y, Byndloss MX, Tsolis RM, et al. Dysbiotic proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017;39:1–6. doi:10.1016/j.mib.2017.07.003
   PubMed Web of Science ®Google Scholar
• Vatanen T, Franzosa EA, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562(7728):589–594. doi:10.1038/s41586-018-0620-2
   PubMed Web of Science ®Google Scholar
• Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251–1262. doi:10.1038/s41430-020-0607-6
   PubMed Web of Science ®Google Scholar
• Fukui H. Role of gut dysbiosis in liver diseases: what have we learned so far? Diseases. 2019;7(4):58. doi:10.3390/diseases7040058
   Web of Science ®Google Scholar
• Shi Y, Kellingray L, Zhai Q, et al. Structural and functional alterations in the microbial community and immunological consequences in a mouse model of antibiotic-induced dysbiosis. Front Microbiol. 2018;9:1948. doi:10.3389/fmicb.2018.01948
   Web of Science ®Google Scholar
• Garrett WS, Gallini CA, Yatsunenko T, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8(3):292–300. doi:10.1016/j.chom.2010.08.004
   PubMed Web of Science ®Google Scholar
• Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiol Spectr. 2019;7(4). doi:10.1128/microbiolspec.GPP3-0053-2018
   PubMed Web of Science ®Google Scholar
• Hassan MA, Abd El-Aziz S, Elbadry HM, et al. Prevalence, antimicrobial resistance profile, and characterization of multi-drug resistant bacteria from various infected wounds in North Egypt. Saudi J Biol Sci. 2022;29(4):2978–2988. doi:10.1016/j.sjbs.2022.01.015
   PubMed Web of Science ®Google Scholar
• Rashid T, Ebringer A, Wilson C. The role of Klebsiella in Crohn’s disease with a potential for the use of antimicrobial measures. Int J Rheumatol. 2013;2013:610393. doi:10.1155/2013/610393
   PubMedGoogle Scholar
• Hassan MA, Tamer TM, Rageh AA, et al. Insight into multidrug-resistant microorganisms from microbial infected diabetic foot ulcers. Diabetes Metab Syndr. 2019;13(2):1261–1270. doi:10.1016/j.dsx.2019.01.044
   Web of Science ®Google Scholar
• Bouza E, Cercenado E. Klebsiella and Enterobacter: antibiotic resistance and treatment implications. Semin Respir Infect. 2002;17(3):215–230. doi:10.1053/srin.2002.34693
   Google Scholar
• Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420–2428. doi:10.1038/ajg.2010.281
   PubMed Web of Science ®Google Scholar
• Wu Z, Xu Q, Gu S, et al. Akkermansia muciniphila Ameliorates Clostridioides difficile infection in mice by modulating the intestinal microbiome and metabolites. Front Microbiol. 2022;13:841920. doi:10.3389/fmicb.2022.841920
   PubMed Web of Science ®Google Scholar
• Rao Y, Kuang Z, Li C, et al. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021;13(1):1–19. doi:10.1080/19490976.2021.1927633
   PubMed Web of Science ®Google Scholar
• Khan I, Wei J, Li A, et al. Lactobacillus plantarum strains attenuated DSS-induced colitis in mice by modulating the gut microbiota and immune response. Int Microbiol. 2022;25(3):587–603.
   Web of Science ®Google Scholar
• Sencio V, Machelart A, Robil C, et al. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. Gut Microbes. 2022;14(1):2018900. doi:10.1080/19490976.2021.2018900
   PubMed Web of Science ®Google Scholar
• Awoniyi M, Wang J, Ngo B, et al. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC. Gut. 2022:gutjnl-2021–326500. doi:10.1136/gutjnl-2021-326500
   Web of Science ®Google Scholar